Download PDF
Thromb Haemost 1989; 62(04): 1053-1056
DOI: 10.1055/s-0038-1647116
Original Article
Clinical Studies
Schattauer GmbH Stuttgart

Association of Reduced Factor VIII with Impaired Platelet Reactivity to Adrenalin and Collagen after Total Thyroidectomy

G Palareti
The Dept. of Angiology and Blood Coagulation, University of Bologna, Italy
,
G Biagi
The Dept. of Angiology and Blood Coagulation, University of Bologna, Italy
,
C Legnani
The Dept. of Angiology and Blood Coagulation, University of Bologna, Italy
,
D Bianchi
1   The Division of Internal Medicine, Bentivoglio Hospital, Bologna, Italy
,
D Serra
2   The Institute of Medical Pathology, University of Bologna, Italy
,
R Savini
2   The Institute of Medical Pathology, University of Bologna, Italy
,
S Coccheri
The Dept. of Angiology and Blood Coagulation, University of Bologna, Italy
› Author Affiliations
Further Information

Publication History

Received 26 June 1989

Accepted after revision 26 September 1989

Publication Date:
24 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Twenty-one thyroprival patients, previously submitted to total thyroidectomy for tumours, were investigated during stabilized L-thyroxine supplementation and at the end of a 20-25 day “no-therapy” period, necessary for a 131I total body scintigraphy. During supplementation therapy a lower than normal mean betathromboglobulin (beta-TG) release level was found, the other blood clotting and platelet function tests being normal. After substitution therapy withdrawal, platelet function tests showed reduced adrenalin aggregation, increased collagen threshold aggregating concentrations, decreased beta-TG release values and reduced aggregation to ristocetin, whereas blood clotting tests showed prolonged aPTT values and reduced levels of factor VIII: C and vWf: Ag. We conclude that in acquired hypothyroidism the lowering of factor VIII: C and vWf: Ag (acquired von Wille brand disease) is associated with impaired platelet reactivity not only to ristocetin but also to collagen and especially adrenalin. In the patients investigated these changes were almost completely corrected by substitutive therapy with L-thyroxine at clinically effective doses.

Keywords

Acquired hypothyroidism - L-thyroxine treatment - Factor VIII - Platelet function - Adrenalin aggregation
 

  • References

  • 1 Orr FR. Haemorrhage in myxoedema coma. Lancet 1962; 2: 1012-1015
    PubMedGoogle Scholar
  • 2 Egeberg O. Influence of thyroid function on blood clotting system. Scand J Clin Lab Invest 1963; 15: 1-7
    CrossrefPubMedGoogle Scholar
  • 3 Edson JR, Fecher DR, Poe RP. Low platelet adhesiveness and other hemostatic abnormalities in hypothyroidism. Ann Intern Med 1975; 82: 342-346
    CrossrefPubMedGoogle Scholar
  • 4 Granata A, Barbera CM, Benvenga S, De Luca F, Vermiglio F, Sobbrio GA, Trimarchi G. Clotting disorders (reduced Factor VIII and prolonged activated partial thromboplastin time) and coagulation inhibitors in primary hypothyroidism. J Lab Med 1986; 13: 325-328
    PubMedGoogle Scholar
  • 5 Dalton RG, Savidge GF, Matthews KB, Dewar MS, Kernoff PBA, Greaves M, Preston FE. Hypothyroidism as a cause of acquired von Willebrand’s disease. Lancet 1987; 1: 1007-1009
    PubMedGoogle Scholar
  • 6 Smith SR, Auger MJ. Hypothyroidism and von Willebrand’s disease. Lancet 1987; 1: 1314
    PubMedGoogle Scholar
  • 7 Mac Callum PK, Rodgers M, Taberner DA. Hypothyroidism and von Willebrand’s disease. Lancet 1987; 1: 1314
    PubMedGoogle Scholar
  • 8 Thorton JG, Parapia LA, Minford AM B. Hypothyroidism and von Willebrand’s disease. Lancet 1987; 1: 1314
    PubMedGoogle Scholar
  • 9 Takahashi H, Yamada M, Shibata A. Acquired von Willebrand’s disease in hypothyroidism. Thromb Haemostas 1987; 58: 1095
    PubMedGoogle Scholar
  • 10 Ivy AC, Nelson AD, Buchet G. The standardization of certain factors in the cutaneous “venostasis” bleeding time technique. J Lab Clin Med 1941; 26: 1812-1822
    PubMedGoogle Scholar
  • 11 Born GV R, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168: 178-195
    CrossrefPubMedGoogle Scholar
  • 12 Prosdocimi M, Zatta A, Zanetti A, Dejana E. Action of AD6 (8-monochloro-3 beta-diethylaminoethyl-4 methyl-7 ethoxycarbonyl-methoxy-coumarin) on human platelets in vitro. NaunynSchmiedeberg’s Arch Pharmacol 1986; 332: 305-310
    PubMedGoogle Scholar
  • 13 Ludlam CA, Moore S, Bolton AE, Pepper DS, Cash JD. The release of a human platelet specific protein measured by a radioimmunoassay. Thromb Res 1975; 6: 543-548
    CrossrefPubMedGoogle Scholar
  • 14 Becker C. Hypothyroidism and atherosclerotic heart disease:pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocrine Rev 1985; 6: 432-440
    CrossrefPubMedGoogle Scholar
  • 15 Rogers JS, Shane RS, Jencks FS. Factor VIII activity and thyroid function. Ann Intern Med 1982; 97: 713-716
    CrossrefPubMedGoogle Scholar
  • 16 Rogers JS, Shane RS. Factor VIII activity in normal volunteers receiving oral thyroid hormone. J Lab Clin Med 1983; 102: 444-449
    PubMedGoogle Scholar
  • 17 Ingram GI C, Jones RV. The rise in clotting factor VIII induced in man by adrenaline: effect of alpha and beta blockers. J Physiol 1966; 187: 447-454
    CrossrefPubMedGoogle Scholar
  • 18 Ziegler ZR, Hasiba U, Lewis JH, Vagnucci AH, West VA, Bezek EA. Hemostatic defects in response to aspirin challenge in hypothyroidism. Am J Hematol 1986; 23: 391-399
    CrossrefPubMedGoogle Scholar
  • 19 Van Doormaal JJ, Van der Meer J, Oosten HR, Halie MR, Doorenbos H. Hypothyroidism leads to more small-sized platelets in circulation. Thromb Haemostas 1987; 58: 964-965
    PubMedGoogle Scholar
  • 20 Ford HC, Carter JM. Moderate, chronic hypothyroidism does not lead to more small-sized platelets in the circulation. Thromb Haemostas 1988; 60: 524
    PubMedGoogle Scholar
  • 21 Van Doormaal JJ, Van der Meer J, Oosten HR, Halie MR, Doorenbos H. A thyroid hormone influences number and size of platelets - Rebuttal. Thromb Haemostas 1988; 60: 525
    PubMedGoogle Scholar
  • 22 Pareti FI, Gugliotta D, Mannucci L, Guarini A, Mannucci PM. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders. Thromb Haemostas 1982; 47: 84-89
    PubMedGoogle Scholar
  • 23 Weiss RJ, Smith CB. Altered platelet alpha-2 adrenoceptors in chronic congestive heart failure. Am J Cardiol 1983; 2: 631-637
    CrossrefPubMedGoogle Scholar
  • 24 Hollister AS, Fitzgerald GA, Nadeau JH, Roberson D. Acute reduction in human platelet alpha-2-adrenoceptor affinity for agonist by endogenous catecholamines. J Clin Invest 1983; 72: 1498-1505
    CrossrefPubMedGoogle Scholar
  • 25 Bilezikian JP, Loeb JN. The influence of hyperthyroidism and hypothyroidism on and adrenergic receptor systems and adrenergic responsiveness. Endocrine Rev 1983; 4: 378-388
    CrossrefPubMedGoogle Scholar